| JYHZ2300262 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | License Renew | 2023-06-15 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
| CYHB2500557 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-03-18 | | Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| CYHS2101239 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs(4) | Generic Drug | 2021-06-10 | | Beijing Baimeite Biopharmaceutical Co Ltd | | | view |
| JYHB2500027 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2025-01-18 | | Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
| CYHS2404593 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs(4) | Generic Drug | 2024-12-28 | | Hunan Common Medicine Technology Co Ltd;Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| CYHB2450346 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2024-07-02 | | Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical Co Ltd | | | view |
| CYHB2400769 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-06-06 | | Beijing Baimeite Biopharmaceutical Co Ltd | | | view |
| J0300753 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | License Renew | 2004-02-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2004-08-06 | view |
| Y0410605 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2004-09-20 | 哈药集团三精制药有限公司 | Harbin Pharm Group Sanjing Pharmaceutical Co Ltd | Certificate Issued | 2005-02-04 | view |
| CYHS0600679 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs(6) | Generic Drug | 2006-04-10 | 广东邦民制药厂有限公司 | Guangdong Bangmin Pharmaceutical Factory Co Ltd | Certificate Issued | 2008-05-21 | view |
| JYHB1000096 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2010-02-23 | | Glaxo Wellcome SA;GlaxoSmithKline SA | Certificate Issued | 2011-05-19 | view |
| CYHB1200302 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2012-05-21 | 哈药集团三精明水药业有限公司 | Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical Co Ltd | Certificate Issued | 2013-01-22 | view |
| JYHZ1800210 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | License Renew | 2018-07-26 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Certificate Issued | 2019-04-15 | view |
| JYHB1701217 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2017-10-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Certificate Issued | 2019-11-08 | view |
| JYHB2001386 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-09-09 | view |
| JYHB2100178 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2021-03-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-03-05 | view |
